Volume : 10, Issue : 11, November – 2023

Title:

FORMULATION AND EVALUATION OF NASAL IN- SITU GEL FOR THE TREATMENT OF MIGRAINE

Authors :

Roshani Sawarkar, Shrikant Pande

Abstract :

The aim of the present study is to overcome the limitations of nasal cavity like low residence time by using in situ gel forming nasal drug delivery system prepared from polymers that exhibit phase transition (Sol-Gel) and pseudo plastic behaviour to minimize interference within the mucociliary clearance. It the increasing of the delivery residence of the delivery system and enhancing bioavailability. Rizatriptan benzoate is a selective serotonin (5-hydroxytryptamine; 5-HT) type 1B and 1D receptor agonist (“triptan”) commonly used for the treatment of a migraine and completely absorbed from GIT, but absolute bioavailability (as conventional tablet) is 45%, indicating the first-pass metabolism, which is due to the metabolism of the drug by monoamine oxidase A isoenzyme (MAO-A) to an inactive indole acetic acid metabolite with the advent of new era of pharmaceutical dosage forms, nasal drug delivery system has established itself as an integral part of novel drug delivery system. Nasal gel is prepared by using gelling agent such as Chitosan HCL, HPMC K4M, Carbopol 934, Sodium alginate, Gellun gum and Sod. β-Glycerophosphate and other excipients. Optimized Batch PF9 was observed to be the best batch.
Keywords: Rizatriptan benzoate, Chitosan HCL, Sod. β-Glycerophosphate , Sodium alginate.

Cite This Article:

Please cite this article in Roshani Ashok Sawarkar et al, Formulation And Evaluation Of Nasal In- Situ Gel For The Treatment Of Migraine, Indo Am. J. P. Sci, 2023; 10 (11).

Number of Downloads : 10

References:

1. Ashim K. Mitra ophthalmic drug delivery system, second edition, Revised and expanded, University of Misssouri Kansas City, Missouri, U.S.A copyright 2003 Marcel Dekker, Inc
2. Gibaldi M and Perrier D. Pharmacokinetics. New York: Marcel Dekker, 1982.
3. Cho KY, Chung TW, Kim BC, Kim MK, Lee JH, Wee WR, et al. Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro. Int. J. Pharm. 2003; 260: 83–91.
4. Cho KY, Chung TW, Song HH, Choi YJ, Kwon JW, Kim MK, et al. Release of ciprofloxacin from chondroitin 6-sulfategraft poloxamer hydrogel in vitro for ophthalmic drug delivery. Drug Dev. Ind. Pharm. 2005; 31:455-463.
5. Aggarwal D, Kaur IP. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int. J. Pharm. 2005; 290: 155–159. 7.
6. Sultana Y, Aqil M, Ali A, Zafar S. Evaluation of carbopolmethyl cellulose based sustained-release ocular delivery system for pefloxacin mesylate using rabbit eye model. Pharm. Dev. Technol. 2006; 11: 313–319.

7. Gurny R, Boye T, Ibrahim H. Ocular therapy with nanoparticulate systems for controlled drug delivery. J. Control. Release. 1985; 2: 353–361.
8. Balasubramaniam J, Kant S, Pandit J K. In vitro and in vivo evaluation of the Gelrite gellan gum-based ocular delivery system for indomethacin. Acta Pharm. 2003; 53: 251–261.
9. Balasubramaniam J, Pandit JK. Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride. Drug Deliv. 2003; 10: 185–191.
10. Liu Z, Li J, Ni S, Liu H, Ding P, Pan W. Study of an alginate/ HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. Int. J. Pharm. 2006: 315: 12–17.
11. Illum L. Nasal drug delivery possibilities, problems and solution, J Control Rel. 2003, 87: 187-198.
12. Mao K, Chen J, Wie Z, Lie H, Bi D. Intranasal administration of melatonin starch microspheres, Int. J. Pharm, 2004,272:37-43
13. Osth K, Paulsson, Bjork G, Edsman K. Evaluation of drug release from gel on pig nasal mucosa in a horizontal using chamber, J. Control. Rel. 2002, 83:377-388.
14. WadellC, Bjork E, Camber O.Nasal drug deliver evaluation of an in vitro model using porcine nasal mucosa, Eur. J. Pharm.Sci.1999, 7:197-206.
15. Khedkar A, Rajendra V, Kulkarni A, Dehghan MH, Saifee M, Lahoti S. Spectrophotometric method for analysis of rizatriptan benzoate. Int J Pharm Sci 2009;1:307-13.Biomed Pharma Sci 2015;5:13-9.
16. Prasanta S, Padma MS. Estimation of rizatriptan benzoate tablet by using uv spectrophotometric methods. Int J Pharm Sci Res 2013;19:97-100
17. Illume, Elisabeth. “Transport of drugs from the nasal cavity to the central nervous System” Lage Journal of Pharmaceutical Sciences11, no. 1 (2000) 1-18.
18. Behl, C. R., H. K. Pimplaskar, A. P. Sileno, and V. D. Romeo. “Effects of Physicochemical ties and other factors on systemic nasal drug delivery.” Advanced drug delivery reviews 29 no. 1 (1998) 89-116.
19. Parvathi, M. “Intranasal drug delivery to brain: an overview.” International Journal of research in pharmacy and chemistry 2, no.3 (2012) 889-95.
20. Sarkar, Mohammad A. “Drug metabolism in the nasal mucosa.” Pharmaceutical Research, no. 1(1992) 1-9.
21. Pranjoty, K.I. K “Gel as tropical applications Indian drugs Bombay 31 (1994) 224-224
22. Raymond C. Rowe, J. Sheskey Paul and C. Owen Sian Handbook Pharmaceutical excipient “American pharmaceutical association, Washington DC (2006)436-433
23. pharmacopoeia (1996), vol. Government of India, ministry of health and lily well, published by controller of publication Delhi A-147.
24. Chavanputil. Mahesh D. and Pradeep R. Vavia: “Theinfluence of absorption Enhancers serption of acyclovir. European journal of pharmaceutics biopharmaceutics 57, 0.3 (2004)483-487.
25. Ellady, SS Abd, NabedD. Mortada, Gehanne AS Awad, Noha M. Zaki, and Ragis A. Taha Development of in situ gelling and mucoadhesivemebeverine hydrochloride Solution for rectaal altinistration.” Saudi pharmaceutical journal 11 no.4 (2003) 59-171.
26. Maitani, Yoshie. Setuko Asano, Satomi Takahashi, Masayuki Nakagaki, and tsunami nagai Permeability of insulin entrapped in liposome through the nasal mucosa of rabbits” chemical and pharmaceutical bulletin 40, no.6 (1992) 1569-1572
27. Wadell, Cecilia, Erik Bjork, and Ola Camber. “Nasal drog delivery evaluation of an in Vitro model using porcine nasal mucosa.” European Journal of pharmaceutical sciences 7, no 3 (1999) 197-206.
28. UgwokeMI Agu Ro, JorisseM. Augustijn P. Sciot R. Verbeke N, et al. Toxicological investigations of the effects of carboxymethyl cellulose on ciliary beat frequency of human epithelial cells in primary suspension culture and in vivo on rabbit nasal mucosa. Int. J. Pharm 2000 201 33-51.
29. Guideline. ICH Harmonised Tripartite Stability testing of new drug substances and Products QIA (R2), Current Step4.2003.